News & Events
Crinetics Reports Fourth Quarter and Full Year 2022 Financial Results
Crinetics Pharmaceuticals reported financial results for the fourth quarter and year ended December 31, 2022
READ MORECrinetics Announces February 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces February 2023 inducement grants: the stock options were granted as inducements material to six employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
READ MORECrinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference
Crinetics Pharmaceuticals will participate in a fireside chat at the annual SVB Securities Global Biopharma Conference on February 14, 2023.
READ MORECrinetics Announces January 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces January 2023 inducement grants: the stock options were granted as inducements material to six employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
READ MORECrinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference
Crinetics provides a company update at the 41st Annual J. P. Morgan Healthcare Conference on Wednesday, January 11th at 3:00 p.
READ MORECrinetics Announces December 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces December 2022 inducement grants: the stock options were granted as inducements material to 12 employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
READ MORECrinetics Pharmaceuticals Provides Update on CRN04777 Program
Crinetics provided an update on development of CRN04777, an investigational, oral somatostatin receptor type 5 (SST5) agonist being developed as a treatment for congenital hyperinsulinism
READ MORETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
